Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
Research highlights Biomarkers that would predict response to neoadjuvant chemotherapy in advanced ovarian cancer patients are eagerly needed: • Neutrophil to Lymphocyte Ratio (NLR) is an indicator of systemic inflammatory response to the malignancy. • NLR was evaluated in 132 patients undergoing Ne...
Enregistré dans:
Auteurs principaux: | M. Liontos, A. Andrikopoulou, K. Koutsoukos, C. Markellos, E. Skafida, O. Fiste, M. Kaparelou, N. Thomakos, D. Haidopoulos, A. Rodolakis, M. A. Dimopoulos, F. Zagouri |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b86ff7d8ecf44fa4ad5387a7df88a008 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Fever during chemotherapy: Hypersensitivity reactions
par: Wen-Ling Lee, et autres
Publié: (2021) -
Treatment of Cervical Pregnancy with Ultrasound-Guided Intragestational Injection of Methotrexate: A Case Report
par: Angeliki Rouvali, et autres
Publié: (2021) -
Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
par: Allan B. Huang, et autres
Publié: (2021) -
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
par: Mitchell Clark, et autres
Publié: (2021) -
Correction to: Maternal and neonatal outcomes in mothers with diabetes mellitus in Qatari population
par: Mohammad A. A. Bayoumi, et autres
Publié: (2021)